2 Monster Stocks to Buy Without Any Hesitation
These stocks have grown revenue, earnings and share price over the past five years.
Mindfully Curated
These stocks have grown revenue, earnings and share price over the past five years.
These stocks have grown revenue, earnings and share price over the past five years.
Apple’s growth rate has slowed, but investors shouldn’t count on that trend continuing for too long.
Apple’s growth rate has slowed, but investors shouldn’t count on that trend continuing for too long.
Contrarian investors are thinking about buying Chinese companies. But which is a better bet?
Contrarian investors are thinking about buying Chinese companies. But which is a better bet?
The past three years have been difficult for the company, but the future still looks bright.
The past three years have been difficult for the company, but the future still looks bright.
This little-known internet platform could be a long-term winner.
This little-known internet platform could be a long-term winner.
The fitness disruptor has been on a wild ride over the past few years.
The fitness disruptor has been on a wild ride over the past few years.
These companies are excellent options to buy and hold indefinitely, as they’re almost guaranteed to rise over the long term.
These companies are excellent options to buy and hold indefinitely, as they’re almost guaranteed to rise over the long term.
The iconic money manager with a penchant for aggressive growth is staying active as her exchange-traded funds bounce back in 2023.
The iconic money manager with a penchant for aggressive growth is staying active as her exchange-traded funds bounce back in 2023.
They aren’t in any danger of crimping their dividends.
They aren’t in any danger of crimping their dividends.
Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker’s growth trajectory post-2025.